Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
{{familytree | | | | | |!| | | | | | | | | | | | |!| | }} | {{familytree | | | | | |!| | | | | | | | | | | | |!| | }} | ||
{{familytree | |,|-|-|-|+|-|-|-|.| | | | | | |,|-|^|-|.| | | }} | {{familytree | |,|-|-|-|+|-|-|-|.| | | | | | |,|-|^|-|.| | | }} | ||
{{familytree | F01 | |F02| | F03 | {{familytree | F01 | |F02| | F03 | | | | F04| | |F05| | | | |F01=bone|F02=Ing|F03=Supra|F04=dasd|F05=asd}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:47, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Neuroendocrine carcinoma | Adenocarcinoma and poorly differntiated carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||
| Additional tests specific to location of metastasis | • Octreoscan • Plasma chromogranin A | Gender specific tests | |||||||||||||||||||||||||||||||||||||||||||||||||
| bone | Ing | Supra | dasd | asd | |||||||||||||||||||||||||||||||||||||||||||||||